Leading science, pioneering therapies

CRM Publications

Found 59 results
Filters: Keyword is Mutation  [Clear All Filters]
Lathe R.  1996.  Mice, gene targeting and behaviour: more than just genetic background.Trends Neurosci. 19(5):183-6;discussion188-9.
Serafini T, Colamarino SA, Leonardo ED, Wang H, Beddington R, Skarnes WC, Tessier-Lavigne M.  1996.  Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system.Cell. 87(6):1001-14.
Zmuidzinas A, Fischer KD, Lira SA, Forrester LM, Bryant S, Bernstein A, Barbacid M.  1995.  The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro.EMBO J. 14(1):1-11.
Grant SG.  1994.  Gene targeting and synaptic plasticity.Curr Opin Neurobiol. 4(5):687-92.
Sharp MG, Mullins JJ.  1993.  Loss of gene function methodology.J Hypertens. 11(4):339-43.
Mombaerts P, Clarke AR, Rudnicki MA, Iacomini J, Itohara S, Lafaille JJ, Wang L, Ichikawa Y, Jaenisch R, Hooper ML.  1992.  Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages.Nature. 360(6401):225-31.
Beddington RS, Püschel AW, Rashbass P.  1992.  Use of chimeras to study gene function in mesodermal tissues during gastrulation and early organogenesis.Ciba Found Symp. 165:61-74;discussion74-7.
Rashbass P, Cooke LA, Herrmann BG, Beddington RS.  1991.  A cell autonomous function of Brachyury in T/T embryonic stem cell chimaeras.Nature. 353(6342):348-51.
Ganten D, Lindpaintner K, Ganten U, Peters J, Zimmermann F, Bader M, Mullins JJ.  1991.  Transgenic rats: new animal models in hypertension research. Invited lecture.Hypertension. 17(6 Pt 2):843-55.